Open access · CC-BY
via OpenAlex
Alpha-Synuclein and the Immune Response in Parkinson’s Disease
Cintia Roodveldt, Adahir Labrador‐Garrido, Guillermo Izquierdo, David Pozo
InTech eBooks · 2011 · ▲ 2 citations
Abstract
In the last few years, it has become evident that the immunological component is of central\nimportance in Parkinson’s Disease (PD) pathogenesis and progression. This can also\ncertainly be said about the prominent role that the protein -synuclein (Syn) is currently\nbelieved to play in the pathobiology of this neurodegenerative disorder. Moreover, the\nmultiple mechanisms through which Syn might be affecting the immune system appear\nnot to be just a consequence of disease progression, but to actively contribute to the delicate\nbalance between neuroprotection and neurotoxicity that ultimately underlies a given stage\nof disease.\nPD is a proteinopathy, whose pathological hallmark is the presence of deposits of\naggregated Syn in intracellular fibrillar inclusions in neurons of the substantia nigra pars\ncompacta (SN) of the brain, known as Lewy bodies (LB) (Croisier et al., 2005; Spillantini et al.,\n1998), and the loss of dopaminergic neurons (Braak et al., 2003). Three missense mutations,\nA53T, A30P and E46K, as well as multiple copies of the wild-type (Wt) Syn gene, are\nlinked to early-onset, familial PD (Gasser, 2005; Kruger et al., 1998; Polymeropoulos et al.,\n1997; Zarranz et al., 2004). Given that Syn is the major component of LB in both familial\nand sporadic PD cases (Spillantini et al., 1998), Syn is considered a critical factor in PD\naetiology. Currently, the cellular and molecular mechanisms underlying the pathological\nactions of Syn are poorly understood, and the factors contributing to sporadic PD,\nrepresenting the vast majority of PD cases, are not known.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5772/17417
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Roodveldt, C., Labrador‐Garrido, A., Izquierdo, G., & Pozo, D. (2011). Alpha-Synuclein and the Immune Response in Parkinson’s Disease. <em>InTech eBooks</em>. https://doi.org/10.5772/17417
Vancouver
Roodveldt C, Labrador‐Garrido A, Izquierdo G, Pozo D. Alpha-Synuclein and the Immune Response in Parkinson’s Disease. InTech eBooks. 2011. doi:10.5772/17417.
BibTeX
@article{cintia2011AlphaS,
title = {Alpha-Synuclein and the Immune Response in Parkinson’s Disease},
author = {Cintia Roodveldt and Adahir Labrador‐Garrido and Guillermo Izquierdo and David Pozo},
journal = {InTech eBooks},
year = {2011},
doi = {10.5772/17417},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current opinion in neurobiology 2026
Citation only
Implications of cellular senescence in Parkinson's disease: Recent developments and future directions.
Experimental Neurobiology 2014
Open access · OA
Alpha-Synuclein Function and Dysfunction on Cellular Membranes
npj Parkinson s Disease 2021
Open access · CC-BY
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Biomolecules 2015
Open access · CC-BY
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine 2010
Preprint · OA
Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease
Expert Review of Proteomics 2008
Citation only